Nutrishare Inc
Letter data
- Company
- Nutrishare Inc
- Recipient
- Rodney J. Okamoto | Owner and President | Nutrishare Inc | 9850 Kent Street | Elk Grove | , | CA | 95624 | United States
- Issue date
- 2020-03-04
- Posted date
- Not available
- FDA office
- Division of Pharmaceutical Quality Operations III
- Subject
- Not available
- Product
- Drugs
- CMS ID
- 543730
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Nutrishare Inc
MARCS-CMS 543730 —
March 04, 2020
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
UPS Next Day
Product:
Drugs
Recipient:
Recipient Name
Rodney J. Okamoto
Recipient Title
Owner and President
Nutrishare Inc
9850 Kent Street
Elk Grove
,
CA
95624
United States
Issuing Office:
Division of Pharmaceutical Quality Operations III
United States
(313) 393-8100
Dear Mr. Okamoto:
The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter [Case #543730, January 16, 2018]. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Nicholas F. Lyons
Compliance Director
Division of Pharmaceutical Quality Operations III
cc: Gregory M. Killmeier
Operations Manager & Pharmacist in Charge
Nutrishare Inc.
11020 Plantside Drive
Louisville, KY 40299-6105
Content current as of:
03/04/2020
Regulated Product(s)
Drugs